Hutchin Hill Capital’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Hutchin Hill Capital’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-10,451	Closed	-$1.05M	–	934
2015 Q1	$1.05M	Buy	+10,451	New	+$696K	0.03%	431

Hutchin Hill Capital's ASPX Position: Q2 2015 in Review

Hutchin Hill Capital sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 10,451 shares — an estimated $1.05M sold.

Hutchin Hill Capital first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $1.05M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

Hutchin Hill Capital reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Hutchin Hill Capital sold 10,451 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $1.05M.
Hutchin Hill Capital first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
Hutchin Hill Capital's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.05M in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Hutchin Hill Capital's 13F filing for Q2 2015, filed 14 Aug 2015.